Hormone risk factors during breast tumoral promotion, progression and prognosis;Factores de riesgo hormonal durante la promoción, progresión y pronóstico tumoral mamario

Ginecologia y Obstetricia de Mexico

Volumn 72, Issue 11, 2004, Pages 545-549

  Esquivel, Edith Lucía Salazar ^a,c   López, Adrián Paredes ^a   Sánchez, Leobardo Calzada ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Health Center (T III) Dr Manuel Escondria   (Mexico)

^c NONE   (Mexico)

Author keywords

Risk factors; Serious prognostic; Tumour progression

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMARY GLAND; MENARCHE; MENOPAUSE; NULLIPARA; PARITY; POSTMENOPAUSE; PROGNOSIS; RISK FACTOR; TUMOR GROWTH; ADULT; AGED; BREAST TUMOR; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY;

HORMONE;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HORMONES; HUMANS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 22344453903     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Zumoff B. Hormonal profiles in women with breast cancer. Anticancer Res 1988;8:627-36.
2. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403-7.
3. Vihko R, Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem 1984;20:231-6.
4. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
5. Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 1997;216:28-43.
6. Kvale G, Heuch I. A prospective study of reproductive factors and breast cancer. II. Age at first and last birth. Am J Epidemiol 1987;126:842-50.
7. Morabia A, Szhlo M. Nulliparity, infertility and risk of breast cancer among premenopausal women. Am J Epidemiol 1989;130:811-7.
8. White E. Projected changes in breast cancer incidence due to the trend toward delayed childbearing. Am J Public Health 1987;77:495-7.
9. Jacobson HI, Thompson WD, Janerich DT. Multiple births and maternal risk of breast cancer. Am J Epidemiol 1989;129:865-73.
10. Sattin RW, Rubin GL, Webster LA, et al. Family history and the risk of breast cancer. JAMA 1985;253:1908-13.
11. Dupont WD, Page DL. Cancer risk in benign breast disease. Reviews on endocrine-related cancer 1989;32:5-9.
12. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. Cancer 1985;55:2698-708.
13. Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990;65:518-29.
14. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
15. Goldin BR, Adlercreutz H, Gorbasch SL, et al. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 1987;44:945-53.
16. Sutherland RL, Reddel RR, Green MD. Effects of oestrogenous on cell proliferation and cell cycle kinetics: a hypothesis on the cell cycle effects of antioestrogenous. Eur J Cancer Clin Oncol 1983;19:307-18.
17. Hess RA, Bunick D, Lee KH, et al. A role for estrogens in the male reproductive system. Nature 1997;390:509-12.
18. Kvale C, Heuch IA. Prospective study of reproductive factors and breast cancer. I. Parity. Am J Epidemiol 1987;126:831-41.
19. Hiatt RA, Bawol R, Friedman GD, Hoover R. Exogenous estrogen and breast cancer after bilateral oophorectomy. Cancer 1984;54:139-44.
20. Lipworth L, Bailey LR, Trichopoulos D. History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst 2000;92:302-12.
21. Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002;346:2025-32.
22. Rosenberg L, Palmer JR, Rao RS. Case-control study of oral contraceptive use and risk of breast cancer. Am J Epidemiol 1996;143:25-31.
23. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
24. Magnusson CM, Baron J, Correia N. Breast cancer risk following long-term oestrogen and oestrogen-progestin-replacement therapy. Int J Cancer 1999;81:339-44.
25. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight and breast cancer risk. Am J Epidemiol 2000;152:514-27.
26. Hunter DJ, Willet WC. Diet, body size and breast cancer. Epidemiol Rev 1993;15:110-32.